MENU

Published on 19/10/2020 12:58:58 PM | Source: Angel Broking Ltd

Quote on Alembic Pharmaceuticals Ltd By Mr. Yash Gupta, Angel Broking Ltd  ​​​​​​​

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel  https://t.me/InvestmentGuruIndia 

Download Telegram App before Joining the Channel

Below is the Quote on Alembic Pharmaceuticals Ltd By Mr. Yash Gupta- Equity Research Associate, Angel Broking Ltd  

“Alembic Pharmaceuticals Limited announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Amantadine Hydrochloride Tablets, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product, Symmetrel Tablets, 100 mg, of Endo Pharmaceuticals, Inc. Amantadine Hydrochloride Tablets are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine Hydrochloride Tablets· are also indicated in the treatment of parkinsonism and drug, induced extrapyramidal reactions. Amantadine Hydrochloride Tablets, 100 mg have an estimated market size of US$ 13 million for twelve months ending June, 2020 according to IQVIA. This is positive development for the company.”

 

Above views are of the author and not of the website kindly read disclaimer